1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Basic facts

A. On March 11, 2010, the Plaintiff entered into the instant insurance contract with the Defendant for non-distribution of dividends (hereinafter “instant insurance contract”). On March 11, 201, the Plaintiff concluded the instant insurance contract with the Defendant (hereinafter “instant insurance contract”). On March 11, 201, the Plaintiff’s operating allowance of KRW 24 million (class 3 malicious disease) with the Plaintiff’s KRW 24 million (class 3 malicious disease).

B. The main contents of the instant insurance contract are as follows.

Article 15 [Definition and Confirmation of Diagnosis of Serious Diseases] (1) The term "serious diseases" in this contract refers to "serious cancer", "serious acute eclibrosis," "serious eclibrosis," "serious eclibrosis," "Malibrosis," "Malibrosis," "Malibrosis," "Malibrosis," and "Malibrosis disease," and "Malibrosis."

(4) The diagnosis and confirmation of "serious diseases" and "serious image and corrosion" shall be based on the documentized records or inspection results prepared by a person with a medical license (excluding oriental medical doctors and dentists) of a domestic hospital or a medical institution prescribed by the Medical Service Act in accordance with the provisions of Articles 3 and 5 of the Medical Service Act or by a person with a medical license in a foreign country.

[Attachment 4] Definitions of “Serious Disease”

I. Serious cancer (Cancer) 1 The term "serious cancer" means the amount of malicious species that can be characterized by salvating salvous proliferation of the malicious species Table in existence of a malicious species cell and its surrounding organization, and does not include any of the following cases:

② 암의 진단확정은 해부병리 전문의사 또는 임상병리 전문의사 자격증을 가진 자에 의하여 내려져야 하며, 이 진단은 조직(fixed tissue) 검사, 미세바늘흡인검사(fine needle aspiration) 또는 혈액(hemic system) 검사에 대한 현미경 소견을 기초로 하여야 합니다.

C. The Plaintiff on August 24, 2012